Grason-Stadler (GSI), a company that makes audiometric equipment, has released a new clinical EP/OAE device, the GSI Audera Pro™. The Audera Pro is said to perform all standard evoked potential tests, according to GSI. Depending on the modality license, ASSR (auditory steady state responses) and OAE (otoacoustic emissions) can also be performed. The Audera Pro is the next generation of the GSI Audera™.
Some of the featured new tests include: P300/MMN, ASSR Binaural testing, TEOAE, and Speech Stimuli for ABR. The hardware has been updated to provide a smaller footprint, an integrated pre-amplifier, lightweight cables, and the GSI OAE probe. Modules of the Audera Pro feature predefined protocols and normative data. On-screen options allow for changes in real time. Customized protocols may be added to meet individual testing needs. Audera Pro comes standard with CE-Chirp and CE-Chirp Octave Band stimuli, which have shown wave V amplitudes that are up to two times larger than traditional click-and-tone burst stimuli for threshold estimation. The system also has modern waveform analysis tools such as Area Ratio for ECochG, application of digital filters, the ability to split alternating waveforms into rarefaction and condensation components, cross correlation of waveforms, and automatic SNR (Signal-to-Noise Ratio) and RN (Residual Noise) calculation.
All test modules on the Audera Pro feature data organization designed with efficiency in mind, according to GSI. This includes multiple pages available in a single report to include ABR, ASSR, and OAE data.
The Audera Pro can be used by clinics to “comprehensively evaluate, identify, document, and diagnose auditory and vestibular disorders on all patient populations.”
To learn more about this new versatile device from GSI visit: grason-stadler.com.